Eyegate Pharmaceuticals, Inc. IPO Research Information

Eyegate Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Eyegate Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Eyegate Pharmaceuticals, Inc.	EYEG - NASDAQ	Priced at $6.00	$0.00	$0.00	683K	2/13/2015
Underwriter(s): Aegis Capital Corp, Chardan Capital Markets
Co-Manager(s):
Industry:
Filing(s): Filed 2014-07-30 Terms Added 2014-09-15 Terms Added 2014-11-20 Updated Terms 2015-02-04

About Eyegate Pharmaceuticals, Inc. (adapted from Eyegate Pharmaceuticals, Inc. prospectus):
They are a clinical-stage specialty pharmaceutical company that is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye.

This description is adapted from Eyegate EYEG prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Eyegate EYEG "EYEG" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.